Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$880K
Filings
18
Firms Hired
1
Active Period
2013–2017
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivorship, research and programs in FY 2017. H.R. 6, 21st Century Cures Act, provisions related to funding for cancer research and programs. National Cancer Moonshot Initiative, services and research for cancer survivors. CMS: Comment on notice of benefit and payment parameters for 2018, provisions related to standardized plans, network adequacy, prescription drug benefits, and risk adjustment payments. Congressional efforts to repeal and replace the Affordable Care Act.
Client expense: $40,000 · Firm income: —
Matched citations: H.R. 6
Recognizing the importance of cancer research and the contributions of scientists, clinicians, cancer survivors and other patient advocates across the United States who are dedicated to finding a cure for cancer, and supporting the designation of May 2016 as "National Cancer Research Month".
2016 · second_quarter · Firm: LIVESTRONG FOUNDATION THE
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, survivoship, research and programs in FY 2017. National Cancer Moonshot Initiative, meetings and correspondence to discuss services and research for cancer survivors. Endorsement of H.Res. 717/S. Re. 459, supporting cancer research. Comment submitted to the FDA on the draft project proposal for the expanded access navigator for individual patient access. Comment submitted to the FDA in support of the creation of an Oncology Center of Excellence.
Client expense: $60,000 · Firm income: —
Matched citations: H.Res. 717
Planning Actively for Cancer Treatment (PACT) Act of 2015
2016 · first_quarter · Firm: LIVESTRONG FOUNDATION THE
Comments submitted (with the Cancer Leadership Council) to the Senate Finance Committee on the Policy Options Document of the Bipartisan Chronic Care Working Group, specifically about improved care management for those with cancer. HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program.
Client expense: $50,000 · Firm income: —
Matched citations: HR 2846
Medical Debt Relief Act of 2016
2016 · first_quarter · Firm: LIVESTRONG FOUNDATION THE
FY 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2017. FY 2016 omnibus spending package (P.L. 114-113), including $32 billion for medical research conducted and supported by the National Institutes of Health (NIH). National Cancer Moonshot Initiative, meeting to discuss services and research for cancer survivors. Endorsement of the Senate Medical Debt Relief Act (S.2592).
Client expense: $50,000 · Firm income: —
Matched citations: S.2592
Consolidated Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: HR 2029
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $40,000 · Firm income: —
Matched citations: HR 2772
Planning Actively for Cancer Treatment (PACT) Act of 2015
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on Request for Information Regarding Implementation of the Merit-Based Incentive Payment System, Promotion of Alternative Payment Models, and Incentive Payments for Participation in Eligible Alternative Payment Models.(CMS-3321-NC) Comment letter to CMS on the Proposed Notice of Benefit and Payment Parameters for 2017 (modifications to the standards for qualified health plans and the operations of health insurance exchanges).
Client expense: $40,000 · Firm income: —
Matched citations: HR 2846
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $40,000 · Firm income: —
Matched citations: HR 3020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: HR 3020
Accelerating Biomedical Research Act
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: HR 531
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: HR 6
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $40,000 · Firm income: —
Matched citations: S 1645
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: S 1645
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: S.289
Accelerating Biomedical Research Act
2015 · fourth_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies. Senate Innovations Act, provisions involving increased funding for NIH and FDA. HR 2029, FY2016 Omnibus Appropriations Act, provisions related to increased funding for the NIH. Office of the Vice President, meeting request to discuss moonshot cancer initiative.
Client expense: $40,000 · Firm income: —
Matched citations: S. 318
Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $60,000 · Firm income: —
Matched citations: HR 2772
Planning Actively for Cancer Treatment (PACT) Act of 2015
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 2846, the Planning Activity for Cancer Treatment (PACT) Act of 2015, to amend title XVIII of the Social Security Act to provide for coverage of cancer care planning and coordination under the Medicare program. Comment letter to CMS on proposed rule changes to Medicaid Managed Care, provisions related to quality cancer care (CMS-2390-P, Medicaid and Childrens Health Insurance Program (CHIP) Programs; Medicaid Managed Care, CHIP Delivered in Managed Care, Medicaid and CHIP Comprehensive Quality Strategies, and Revisions Related to Third Party Liability) Comment letter to CMS on proposed changes to Medicare physician fee schedule, provisions impacting care to cancer patients (CMS-1631-P, Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2016)
Client expense: $60,000 · Firm income: —
Matched citations: HR 2846
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $60,000 · Firm income: —
Matched citations: HR 3020
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: HR 3020
Accelerating Biomedical Research Act
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: HR 531
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: HR 6
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: S 1645
Department of the Interior, Environment, and Related Agencies Appropriations Act, 2016
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. HR 2772, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2016, provisions related to non-communicable diseases.
Client expense: $60,000 · Firm income: —
Matched citations: S 1645
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: S.289
Accelerating Biomedical Research Act
2015 · third_quarter · Firm: LIVESTRONG FOUNDATION THE
HR 6, 21st Century Cures Act, provisions related to increased funding for the National Institutes of Health. HR 3020/S 1645, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016, provisions regarding funding for the National Institutes of Health, National Cancer Institute and Centers for Disease Control and Prevention relative to cancer screening, research and programs in FY 2016. S. 318/HR 531, the Accelerating Biomedical Research Act, expressing support for NIH funding. S.289, American Cures Act, expressing support for increased funding at NIH, CDC, and other agencies.
Client expense: $60,000 · Firm income: —
Matched citations: S. 318
Source: Senate LDA